Patent Assignment
Reel/Frame 024900/0722
Security Agreement
Recorded: 2010-08-30
Pages: 13
Assignor
CENERX BIOPHARMA, INC.
Executed: 2010-08-10
Assignees
PERSEUS-SOROS BIOPHARMACEUTICAL FUND, LP C/O AISLING CAPITAL, LLC
888 SEVENTH AVENUE, 30TH FLOOR, NEW YORK, NEW YORK, 10106
L CAPITAL PARTNERS SBIC, LP
10 E. 53RD STREET, 37TH FLOOR, NEW YORK, NEW YORK, 10022
A.M. PAPPAS LIFE SCIENCE VENTURES III, LP
2520 MERIDIAN PARKWAY, SUITE 400, DURHAM, NORTH CAROLINA, 27713
PV III CEO FUND, LP
2520 MERIDIAN PARKWAY, SUITE 400, DURHAM, NORTH CAROLINA, 27713
MORRIS, I. WISTAR, III
234 BROUGHTON LANE, VILLANOVA, PENNSYLVANIA, 19085
Covered Properties
(6)
Polymorphic Form of Fluoro-7-(2,2,2-Trifluoroethoxy) Phenoxathiin-10,10-Dioxide
Dialkylamino Alkyl Esters of Pivagabine as Medicaments for the Treatment of Central Nervous System Disorders
Methods of Treating Rett Syndrome
Application:
12/117,586 →
Publication:
US 2008/0280983
Oral Enteric Antidepressant Formulation
Application:
61/143,764 →
Oral Sustained Release Antidepressant Formulation
Application:
61/143,767 →
Oral Antidepressant Formulation with Reduced Excipient Load
Application:
61/301,907 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 2, 2007
From: C.A. BROT, ELISABETH; KEEFE, DANIEL K., JR.; HANEY, BRIAN P.; METCALFE, NIGEL
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 020065/0104 →
Assignment of Assignor's Interest
Nov 7, 2007
From: ALBANY MOLECULAR RESEARCH, INC.
To: CENERX BIOPHARMA, INC.
Reel/Frame 020085/0087 →
Assignment of Assignor's Interest
Apr 21, 2008
From: RAFFERTY, MICHAEL
To: CENERX BIOPHARMA, INC.
Reel/Frame 020835/0739 →
Assignment of Assignor's Interest
Jul 28, 2008
From: KRISHNAN, RANGA; PANDE, ATUL
To: CENERX BIOPHARMA
Reel/Frame 021305/0349 →
Assignment of Assignor's Interest
Jun 3, 2009
From: BRAND, BARRY SCOTT; FREE, JAMES CECIL
To: CENERX BIOPHARMA, INC.
Reel/Frame 022779/0702 →
Assignment of Assignor's Interest
Jun 3, 2009
From: BRAND, BARRY SCOTT; FREE, JAMES CECIL; BURCH, DANIEL JOSEPH; BARIC, MARK JOSEPH
To: CENERX BIOPHARMA, INC.
Reel/Frame 022779/0896 →
Security Agreement
Jun 11, 2009
From: CENERX BIOPHARMA, INC.
To: MIDCAP FUNDING I, LLC
Reel/Frame 022815/0626 →
Security Agreement
Jun 11, 2009
From: CENERX BIOPHARMA, INC.
To: MIDCAP FUNDING I, LLC
Reel/Frame 022815/0636 →
Security Agreement
Jun 11, 2009
From: CENERX BIOPHARMA, INC.
To: MIDCAP FUNDING I, LLC
Reel/Frame 022815/0674 →
Security Agreement
Jun 11, 2009
From: CENERX BIOPHARMA, INC.
To: MIDCAP FUNDING I, LLC
Reel/Frame 022815/0740 →
Security Agreement
Jun 11, 2009
From: CENERX BIOPHARMA, INC.
To: MIDCAP FUNDING I, LLC
Reel/Frame 022815/0587 →
Security Agreement
Jun 12, 2009
From: CENERX BIOPHARMA, INC.
To: PERSEUS-SOROS BIOPHARMACEUTICAL FUND, LP; L. CAPITAL PARTNERS SBIC, LP; A.M. PAPPAS LIFE SCIENCE VENTURES III, LP; PV III CEO FUND, LP
Reel/Frame 022816/0682 →
Assignment of Assignor's Interest
Oct 20, 2009
From: MIDCAP FUNDING I, LLC
To: MIDCAP FINANCIAL, LLC
Reel/Frame 023397/0175 →
Corrective Assignment to Correct the Nature of Conveyance from "Assignment" to "Other - Assignment of Security Agreement" Previously Recorded on Reel 023397 Frame 0175. Assignor(S) Hereby Confirms the Intellectual Property Security Agreement Assignment.
Nov 12, 2009
From: MIDCAP FUNDING I, LLC
To: MIDCAP FINANCIAL, LLC
Reel/Frame 023509/0882 →
Security Agreement
Jan 19, 2010
From: CENERX BIOPHARMA, INC.
To: PERSEUS-SOROS BIOPHARMACEUTICAL FUND, LP; L CAPITAL PARTNERS SBIC, LP; A.M. PAPPAS LIFE SCIENCE VENTURES III, LP; PV III CEO FUND, L.P.
Reel/Frame 023811/0431 →
Intellectual Property Security Agreement Assignment
Feb 23, 2010
From: MIDCAP FINANCIAL, LLC
To: MIDCAP FUNDING III, LLC
Reel/Frame 023973/0396 →
Assignment of Assignor's Interest
Aug 13, 2010
From: CHEN, ANDREW; CHEN, HAILIANG; FREE, JAMES CECIL; KESHTMAND, MAJID
To: CENERX BIOPHARMA, INC.
Reel/Frame 024835/0811 →
Security Agreement
Jan 10, 2011
From: CENERX BIOPHARMA, INC.
To: MIDCAP FUNDING III, LLC
Reel/Frame 025764/0546 →
Release of Security Interest
Feb 16, 2011
From: PERSEUS-SOROS BIOPHARMACEUTICAL FUND, LP; L CAPITAL PARTNERS SBIC, LP; A.M. PAPPAS LIFE SCIENCE VENTURES III, LP; PV III CEO FUND, LP
To: CENERX BIOPHARMA, INC.
Reel/Frame 025817/0722 →
Release of Security Interest
Feb 16, 2011
From: PERSEUS-SOROS BIOPHARMACEUTICAL FUND, LP; L CAPITAL PARTNERS SBIC, LP; A.M. PAPPAS LIFE SCIENCE VENTURES III, LP; PV III CEO FUND, LP
To: CENERX BIOPHARMA, INC.
Reel/Frame 025817/0462 →
Release of Security Interest
Feb 16, 2011
From: PERSEUS-SOROS BIOPHARMACEUTICAL FUND, LP; L CAPITAL PARTNERS SBIC, LP; A.M. PAPPAS LIFE SCIENCE VENTURES III, LP; PV III CEO FUND, LP
To: CENERX BIOPHARMA, INC.
Reel/Frame 025817/0576 →
Security Agreement
Nov 28, 2011
From: CENERX BIOPHARMA, INC.
To: PERSEUS-SOROS BIOPHARMACEUTICAL FUND, LP; L CAPITAL PARTNERS SBIC, LP; F VIIII OMEGA LLC; A.M. PAPPAS LIFE SCIENCE VENTURES III, LP
Reel/Frame 027284/0495 →
Release of Security Interest
Mar 18, 2013
From: MIDCAP FINANCIAL, LLC
To: CENERX BIOPHARMA, INC.
Reel/Frame 030029/0815 →
Release of Security Interest
Mar 18, 2013
From: MIDCAP FUNDING I, LLC
To: CENERX BIOPHARMA, INC.
Reel/Frame 030030/0048 →
Release of Security Interest
Mar 18, 2013
From: MIDCAP FUNDING III, LLC
To: CENERX BIOPHARMA, INC.
Reel/Frame 030027/0840 →